These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6136481)

  • 1. Experience with combined individualized method of hMG/hCG therapy.
    Samberg I; Tal J; Zilberman A; Oettinger M; Sharf M
    Int J Fertil; 1983; 28(2):85-90. PubMed ID: 6136481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new protocol for individualized hMG therapy by estrogen priming and cervical mucus monitoring.
    Igarashi M; Yazaki C; Yamada K; Taniguchi Y
    Int J Fertil; 1983; 28(2):78-84. PubMed ID: 6136480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum 17beta-estradiol. Index of follicular maturation during gonadotropin therapy.
    Notation AD; Tagatz GE; Steffes MW
    Obstet Gynecol; 1978 Feb; 51(2):204-9. PubMed ID: 622235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A simplified quick semi-quantitative determination of urinary estrogen in non-pregnant female: the application for monitoring of follicular maturation at HMG-HCG therapy].
    Kamata S
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan; 38(1):64-72. PubMed ID: 3081668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The studies on the individualized treatment and hormonal patterns during the administration of HMG-HCG in anovulatory women (author's transl)].
    Kooguchi J; Uemura T; Shiojima Y; Iwasaki H
    Acta Obstet Gynaecol Jpn; 1981 Jun; 33(6):777-85. PubMed ID: 6787830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMG-HCG therapy in patients with hypergonadotropic ovarian anovulation: one pregnancy case report and ovulation and pregnancy rate.
    Tanaka T; Sakuragi N; Fujimoto S; Ichinoe K
    Int J Fertil; 1982; 27(2):100-4. PubMed ID: 6126442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovulation induction with human menopausal gonadotropins.
    Diamond MP; Wentz AC
    Obstet Gynecol Surv; 1986 Aug; 41(8):480-90. PubMed ID: 3090489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of ovulation induction with HMG-HCG therapy by plasma estrogen and progesterone.
    Muechler EK; Kohler D; Huang KE
    Int J Fertil; 1981; 26(4):273-8. PubMed ID: 6120908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian hyperstimulation syndrome following ovulation induction with human menopausal gonadotropin.
    Tulandi T; McInnes RA; Arronet GH
    Int J Fertil; 1984; 29(2):113-7. PubMed ID: 6148315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ovulation induction using clomiphene and human gonadotropins in combined therapy].
    Stilinović K; Jurković D; Grljusić V; Blazek L; Ivanković B
    Jugosl Ginekol Perinatol; 1989; 29(1-2):41-3. PubMed ID: 2500565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovulation induction with human menopausal gonadotrophins: an evaluation of a variable daily dosage regimen.
    Webb-Wilson GJ; Arronet GH
    Int J Fertil; 1977; 22(4):225-31. PubMed ID: 24600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of ovulation and pregnancy in twenty-six patients with primary hypogonadotropic amenorrhea.
    Batrinos ML; Panitsa-Faflia C
    Int J Fertil; 1980; 25(4):257-66. PubMed ID: 6114047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing severe ovarian hyperstimulation syndrome in an in vitro fertilization/embryo transfer program. Use of follicular aspiration after human chorionic gonadotropin administration.
    Vrtovec HM; Tomazevic T
    J Reprod Med; 1995 Jan; 40(1):37-40. PubMed ID: 7722973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of serum progesterone levels at the time of hCG on the release of ova during hMG cycles.
    Check JH; Adelson HG; Stern J; Lauer C
    Int J Fertil; 1992; 37(2):103-5. PubMed ID: 1349590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of human menopausal gonadotropin therapy at the Boston Hospital for Women (1979-1981).
    Jones KP; Ravnikar VA; Schiff I
    Int J Fertil; 1987; 32(2):131-4. PubMed ID: 2883138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stimulation of ovulation with gonadotropins].
    Orlova VG
    Akush Ginekol (Mosk); 1980 Sep; (9):3-5. PubMed ID: 6776837
    [No Abstract]   [Full Text] [Related]  

  • 18. [Monitoring of follicles by ultrasonography during induction with HMG-HCG treatment--especially on the prevention of side effects].
    Ishimaru T; Okamoto S; Kajimura H; Masuzaki H; Huang HJ; Fuchi T; Yamashita T; Imamura S; Imamichi S; Hata T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):721-9. PubMed ID: 3923140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Controlled hyperstimulation in intra-uterine inseminations: hMG-hCG protocol (204 cycles)].
    Abboud P; Delépine B; Pigeon F; Bednarczyk L; Quéreux C
    Contracept Fertil Sex; 1997 Jun; 25(6):463-9. PubMed ID: 9280551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shortened luteal phase after ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin.
    Olson JL; Rebar RW; Schreiber JR; Vaitukaitis JL
    Fertil Steril; 1983 Mar; 39(3):284-91. PubMed ID: 6402386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.